Champoux Jennifer (CIK 2025233) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-25). Recent activity: Buy GLUE (2,175 shares), Sell GLUE (2,175 shares), Buy GLUE (2,176 shares), Sell GLUE (2,176 shares), Buy GLUE (35,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Operating Officer | Buy | 2,175 | $8,656 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Operating Officer | Sell | 2,175 | $43,500 |
| 2026-06-18 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Operating Officer | Buy | 2,176 | $8,660 |
| 2026-06-18 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Operating Officer | Sell | 2,176 | $41,344 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Operating Officer | Buy | 35,000 | $0 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Operating Officer | Sell | 2,629 | $39,882 |
Source: SEC Form 4 filings · as of 2026-06-25